The portfolio is the product

Enevate was an early pioneer in silicon-dominant lithium-ion batteries. Founded in Irvine, California in 2005, it spent two decades and more than $150 million of R&D developing its XFC-Energy and HD-Energy platforms: cells that charge in under five minutes at energy densities above 350 Wh/kg and hold their performance at low temperatures and high discharge rates. Enevate does not manufacture. It licenses the technology to battery makers such as CustomCells and JR Energy Solution and supports their cell development, so its portfolio of more than 650 issued and pending patents, spanning more than a dozen technology categories, is the business.

Noel Whitley led Enevate's legal affairs as General Counsel from 2019. An electrical engineer before he was a lawyer, with degrees from Texas A&M and Georgia Tech, he spent six years at E-Systems and then practised at Sterne Kessler and Antonelli Terry before going in-house. He ran intellectual property at Broadcom for eight years and IP and licensing at Netlist for six, with a stretch running his own IP consultancy in between.

Enevate filed a few dozen patent applications a year on a small company's budget, in a market where the stakes of each one reached the whole business. Because revenue came from licensing rather than products, the portfolio had to be the right shape: broad enough to cover what licensees would build, deep enough to hold up against better-funded competitors, and no wider than the budget allowed. Noel's phrase for it was being "very smart" about how they prosecuted.

That meant knowing, continuously, where Enevate's IP sat in the technical landscape of the battery industry and where competitors were moving. As a small team, Noel's group could not cut corners on that intelligence, but assembling it by hand took weeks, and the legacy tools that promised to map assets to categories by keyword had never given him anything he could use.

Tradespace learned Enevate's technology categories from its own portfolio and let the team explore competitors, portfolios and individual patents by those categories, immediately rather than after weeks of assembly. Because the categorization draws on the company's filings and the wider record rather than keyword matching, the results were richer and, in Noel's words, usable.

The payoff was on both sides of the ledger. In the near term, the team could see how each filing fit the landscape before committing budget to it, and could read competitors' movements without a research project. Over time, Noel expected that insight to compound into a better-tuned portfolio at lower cost. He was also clear that the tool was only half of it: the working relationship with the Tradespace team was unlike anything he had had with a vendor in thirty years of IP practice.